Physician profile
Patrick Kelly
NPI 1043417405
$2,430.18
in general payments reported to CMS, 2019-2025
9 companies · $63.61 in 2025
The $63.61 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,232 · 2020: $357 · 2021: $74.40 · 2022: $616 · 2023: $70.54 · 2024: $17.90 · 2025: $63.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $152.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocompatibles, INC. | $1,025.33 | 2019 | |
| Siemens Medical Solutions USA, INC. | $602.68 | 2022 | |
| Boston Scientific Corporation | $445.04 | 2020-2024 | Spaceoar Vue System - 10ml |
| Varian Medical Systems, INC. | $206.26 | 2019 | |
| Viewray Technologies INC | $74.40 | 2021 | |
| Elekta, INC. | $33.02 | 2025 | Elekta Medical Linear Accelerator |
| Stryker Corporation | $30.59 | 2025 | Spy-Phi System |
| Novartis Pharmaceuticals Corporation | $12.86 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Kelly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.